Jaye Thompson
CIK 1476971 · VP Clinical Reg Affairs · last filed 2024-12-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.36M
Companies
5
Total Filings
34
Lifetime Open-Market Net
$164.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GLSI | VP Clinical Reg Affairs | 264,148 | $24.06 | $6.36M | $164.8K | 23 | 2024-12-27 |
| RPRX | See Remarks | — | $54.87 | — | $0 | 1 | 2016-07-06 |
| REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | Senior Vice President | — | — | — | $0 | 1 | 2013-03-28 |
| Acer Therapeutics Inc. (OPXAW) Delisted | SVP Clinical Dev & Reg Affairs | — | — | — | $0 | 4 | 2013-01-25 |
| REPROS THERAPEUTICS INC. (RPRXZ) Delisted | Director | — | — | — | $0 | 3 | 2012-06-14 |
Recent Filings · Page 3 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-24 | GLSI | Buy (P) | +500 | $8.2K | EDGAR |
| 2022-01-19 | GLSI | Buy (P) | +500 | $9.4K | EDGAR |
| 2022-01-14 | GLSI | Buy (P) | +1,000 | $20.0K | EDGAR |
| 2016-07-06 | RPRX | Grant (A) | — | $0 | EDGAR |
| 2013-03-28 | REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-25 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-14 | REPROS THERAPEUTICS INC. (RPRXZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-10 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-06-03 | REPROS THERAPEUTICS INC. (RPRXZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-02 | REPROS THERAPEUTICS INC. (RPRXZ) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.